Skip to NavigationSkip to content

News

Roche has announced along with its partner Chugai that Hemlibra (emicizumab) has secured approval from the European Commission as a preventative...
Celgene’s Abraxane, in combination gemcitabine, has failed to meet its primary endpoint in a pivotal Phase 3 trial of patients with pancreatic cancer.
A new class of cholesterol lowering drugs may help patients who are unable to take statins, according to a study published in the New England...
Richard Francis is set to step down his role as Chief Executive of Novartis’ generics arm Sandoz after five years’ in the role, citing “personal...
A California jury has ordered American healthcare conglomerate Johnson & Johnson to pay more than $29 million to a woman with mesothelioma who...
Following the surprise resignation of current FDA Commissioner Dr Scott Gottlieb a week earlier, Dr Norman ‘Ned’ Sharpless, Director of the...
Janssen’s ulcerative colitis treatment, Stelara (ustekinumab subcutaneous) has shown positive results as maintenance therapy in phase 3 trials.
Eli Lilly’s Cyramza has succeeded in hitting its primary endpoint at Phase 3 in combination with erlotinib, the company said, as a first-line...
The healthcare industry could take up to five years to stabilise in the event of a no-deal Brexit, according to pharmaceutical industry...
The FDA has approved a new generic version of blood pressure drug valsartan. The approval comes amid shortages in supply after recalls were made in...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches